There is no optimism for this stock anymore. Anyone who had bought into this years ago was filled with promises of major sales growth and comparing it to the breathright takeover by GlaxoSmithKline which they paid $566 million.
I smell another capital raise coming on, keeping the share down so you know who can increase their holdings.
Ann: Change of Director's Interest Notice - MJ, page-7
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)